Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice Concerning Revisions to Full-Year Financial Results Forecasts
CellSource and KAKEN PHARMACEUTICAL Initiate Discussions Toward a New Collaboration Framework
CellSource and Juntendo University Announce Research Findings on New Therapeutic Possibilities for Chronic Cerebral Infarction
Earnings Presentation Q3 FY10 2025
[Summary]Consolidated Financial Results for the Nine Months Ended July 31, 2025 (Under Japanese GAAP)
CellSource, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 45%
CellSource and Solallis Bio Enter into Comprehensive Business Alliance Agreement in the Regenerative Medicine Field
July 2025 Monthly KPI Fiscal Year Ending October 2025
Notice Regarding Change in Representative and Representative Director
June 2025 Monthly KPI Fiscal Year Ending October 2025
Notice Regarding Determination of Terms for Stock Options (Stock Acquisition Rights)
Earnings Presentation Q2 FY10/2025
CellSource, First Half Ordinary Profit Decreases by 95%, Feb-Apr Ordinary Profit Decreases by 57%
CellSource Files International Patent Application for PFC-FD (2.0)
[Summary]Consolidated Financial Results for the Six Months Ended April 30, 2025 (Under Japanese GAAP)
Notice Regarding Issuance of Stock Options(Stock Acquisition Rights) to Employees
Clinical Research Paper on CellSource's PFC-FD Selected as a "Top Viewed Article" in KSSTA
CellSource’s Blood-derived Processing Service Introduced at Hokkaido University Hospital, Department of Orthopedic Surgery
April 2025 Monthly KPI Fiscal Year Ending October 2025
April 2025 Monthly KPI Fiscal Year Ending October 2025